Abstract:Aim: To observe the biocompatibility of β-tricalcium phosphate (TCP)/calcium polyphosphate fiber (CPPF)/poly-levolactic acid (PLLA) composite as a novel bone tissue engineered scaffold by observing the morphology and proliferation of in vitro cultured cells. Methods: The experiment was carried out in the experimental center of Medical College and Institute of Endemic Diseases, Xi'an Jiaotong University from January 2002 to January 2004. 1 β-TCP/CPPF/PLLA scaffold was prepared by the Institute of Composite Materials, Lanzhou Jiaotong University; CPPF was (15.0±1.2) μm in diameter with (3.0± 0.46)% mean biodegradation rate, (1.0±0.2) GPa tensile strength, and (48.0±7.6) GPa; the mean molecular mass of PLLA was 27.6×104. The weight ratio of scaffold composite was β-TCP:CPPF:PLLA=2:3:5. 2 With the proportion of 1 g composite:10 mL extraction mediator, β-TCP/CPPF/PLLA scaffold was extracted by using DMEM containing 0.1 volume fracture fetal bovine serum at 37°C for 24 to 72 hours to prepare the extraction fluid, which was filtered before using. The bone marrow stromal cells (BMSCs) were divided into 3 groups and cultured with β-TCP/CPPF/PLLA maceration extract (experiment group), DMEM culture medium (negative control group) and 6.4 g/L Phenol solutions (positive control group), and the dilution of the maceration extract was divided into 100%, 75%, 50%, and 25%, respectively. 3 The growth and change condition of BMSCs were observed by phase contrast microscope. The growth and proliferation of BMSCs were investigated with MTT method to determine A value and calculate the proliferation rate of cells. Results: 1 On days 1, 2 and 3, the cell number of the positive control group displayed noticeable decrease, and the cells were of pyknosis even disaggregation; the cell number of the experiment group and negative control group was remarkably increased with normal call appearance. 2 At each time point of culture, the cytotoxicity of all groups were grade 0 with more than 80% cell proliferation rate except the positive control group was grade 4 with 0-20% cell proliferation rate; except the positive control group, the A values of experiment groups and negative control group were increased with culture days, and the A value of the positive control group on days 1, 2 and 3 was much lower than other groups (P < 0.01);. there were no significant differences between negative control group and experiment group (P > 0.05). Conclusion: β-TCP/CPPF/PLLA scaffold composite has a negligible influence and differentiation of BMSCs. It has good cell compatibility and no cytotoxicity.

Preliminarily Study of Novel Bionic Scaffold with Nanostructure:Biocompatibility in Vitro

Biocompatibility of novel bionic scaffold with nanostructure

The Comparative Study on the Biocompatibility of Four Kinds of Scaffolds

Experimental Study on Cultivation and Purification of Bone Marrow-Derived Mesenchymal Stem Cells and Its Co-Culture with Chitosan Porous Scaffolds in Vitro

Nanostructured Molybdenum Disulfide Biointerface for Adhesion and Osteogenic Differentiation of Mesenchymal Stem Cells

Preparation and Characterization of Bionic Bone Structure Chitosan/hydroxyapatite Scaffold for Bone Tissue Engineering.

A Morphological Study of the Cellular Biocompatability of a New Bone-Matrix Material in Vitro

A Novel Method to in Vitro Evaluate Biocompatibility of Nanoscaled Scaffolds.

The Biocompatibility Study on Polyhydroxybutyrate/Polyethylene Glycol Nanocomposite Scaffolds

In Vitro Biocompatibility and Osteoblast Differentiation of an Injectable Chitosan/Nano-Hydroxyapatite/Collagen Scaffold

In vitro cytotoxicity study of the nano-hydroxyapatite/bacterial cellulose nanocomposites

Cell compatibility of two novel scaffold materials

Attachment And Proliferation Of Mouse Bone Marrow Stem Cells On Electrospun Chitosan-Based Nanofibrous Scaffolds

Biocompatibility of new nano-structured biomimetic bone matrix co-cultured with goat adipose derived stromal cells

Cell biocompatibility of beta-tricalcium phosphate/calcium polyphosphate fiber/polylevolactic acid composite as a novel bone tissue-engineered scaffold

[Biocompatibility of a Novel Cavernous Nickel-Titanium Alloy with Rat Bone Marrow Stromal Cells in Vitro].

Biological evaluation of bone tissue-engineered nanocomposite scaffold

Comparison of in vitro biocompatibility of NanoBone(®) and BioOss(®) for human osteoblasts

Preliminarily study of a novel porous composite: cytocompatibility in vitro and osteogenesis in vivo

A STUDY OF THE BIOCOMPATIBILITY OF CROSS-LINKED G-PHB AND BONE MARROW STROMAL CELLS IN VITRO

Cellular Affinity of Inorganic Active Element Bone Scaffold Materials